News from cvrx, inc

Jun 09, 2014, 06:00 ET

CVRx® Achieves Two Significant Milestones for its Heart Failure and Hypertension Businesses

 CVRx, Inc., a private medical device company, announced today it achieved two significant milestones in its heart failure and hypertension...

Jan 07, 2014, 06:00 ET

Barostim Therapy™ Projected to be Cost-Effective in Treating Resistant Hypertension

CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of...

Nov 05, 2013, 07:00 ET

CVRx® & DaVita Announce Strategic Partnership

CVRx, Inc., a private medical device company, and DaVita®, a division of DaVita HealthCare Partners Inc, have embarked on a strategic...

Oct 30, 2013, 07:00 ET

CVRx® Closes $12 Million Additional Financing

 CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing.  This brings...

Jul 10, 2013, 18:00 ET

CVRx®, Inc. Closes $29.6 Million Financing

CVRx, Inc., a private medical device company, has completed a private equity financing totaling $29.6 million. CVRx plans to use the funding for...

Apr 29, 2013, 07:00 ET

CVRx® Launches HOPE4HF™ Clinical Trial Evaluating Barostim neo™ in Heart Failure Patients

 CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is...

Apr 29, 2013, 07:00 ET

CVRx® Gains Full FDA Approval for Hypertension Study

CVRx, Inc., a private medical device company, received Food and Drug Administration (FDA) investigational device exemption (IDE) approval, allowing...

Jul 09, 2012, 08:50 ET

CVRx® Names Philippe Wanstok Chief Commercial Officer

 CVRx, Inc., a privately-held medical device company, has appointed Philippe Wanstok to the newly created position of Chief Commercial Officer,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review